Transgene Biotek Limited
Transgene Biotek Limited
Share · INE773D01018 (XBOM)
Overview
No Price
Closing Price XBOM 30.03.2026: 1,98 INR
30.03.2026 10:19
Current Prices from Transgene Biotek Limited
ExchangeTickerCurrencyLast TradePriceDaily Change
XBOM: MSE
MSE
TRABI.BO
INR
30.03.2026 10:19
1,98 INR
-
Share Float & Liquidity
Free Float 66,79 %
Shares Float 50,61 M
Shares Outstanding 75,77 M
Company Profile for Transgene Biotek Limited Share
Transgene Biotek Ltd. is a biotechnology company, which manufactures and sells diagnostic kits. It involves in the production and oral formulation of different proteins using TrabiORAL technology. The firm's products portfolio includes TrabiDHA, Tacrolimus, and Orlistat. The company was founded by K. Koteswara Rao in 1991 and is headquartered in Hyderabad, India.
AI Analysis of Transgene Biotek Limited
Click any analysis below to get instant AI insights from finAgent
Latest AI Analyses of Transgene Biotek Limited
No AI threads available for this company yet.

Company Data

Name Transgene Biotek Limited
Company Transgene Biotek Limited
Website http://www.transgenebiotek.com
Primary Exchange XBOM MSE
ISIN INE773D01018
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Koteswara Rao Kanuru
Market Capitalization 150 Mio
Country India
Currency INR
Employees -
Address Plot No. 69 & 70, Hyderabad
IPO Date 2001-12-31

Ticker Symbols

Name Symbol
MSE TRABI.BO
More Shares
Investors who hold Transgene Biotek Limited also have the following shares in their portfolio:
First Baking Co., Ltd.
First Baking Co., Ltd. Share
iShares MSCI Min Vol Canada Index ETF
iShares MSCI Min Vol Canada Index ETF ETF
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2026